南京澳林生物科技有限公司
Introduction of Nanjing Aubrime Biotechnology Co., LTD.
南京澳林生物科技有限公司是具有全球經營戰略和先進技術的生物醫藥研發、制造、銷售一體化企業，公司成立于2007年，占地26. 6畝,注冊資金2210萬元，以建設“讓全人類共享科學早診高速公路”為己任，以“專注生命、精工精品”為宗旨，目前主要致力于臨床化學及分子生物學診斷試劑產品，檢驗儀器的研究、開發、生產和銷售，以及第三方獨立醫學檢驗平臺的建設。
Nanjing Aubrime Biotechnology Co., Ltd. is a comprehensive company of R&D, manufacturing and marketing of biomedical products, with corporate global strategy and advanced technology. Nanjing Aubrime was founded in 2007, covering an area of 26.6 Chinese Mu, with a registered capital of 22.1 million RMB. With “building early diagnostic expressway” as its duty and “focusing on life, manufacturing product of exquisite quality” as its tenet, Aubrime has been committing itself to the research, development, manufacturing and marketing of laboratory instruments and clinical diagnostic reagents and the construction of independent clinical laboratory platform.
7813 2 年前 
蘇ICP備2023031010號 
蘇公網安備32011102010595號